Assurant (AIZ)
(Delayed Data from NYSE)
$191.76 USD
+0.06 (0.03%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $191.80 +0.04 (0.02%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$191.76 USD
+0.06 (0.03%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $191.80 +0.04 (0.02%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth D Momentum B VGM
Zacks News
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Is Assurant (AIZ) Down 2.6% Since Last Earnings Report?
by Zacks Equity Research
Assurant (AIZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO Financial (CNO) Unit Ties Up to Boost Advocacy Services
by Zacks Equity Research
CNO Financial's (CNO) unit, Optavise, collaborates with SentryHealth to bolster its portfolio of advocacy services and assure the well-being of its employers' workforce.
Assurant (AIZ) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Assurant (AIZ) have what it takes? Let's find out.
Here's Why You Should Stay Invested in Progressive (PGR) Stock
by Zacks Equity Research
Progressive (PGR) seems well poised on improving premium, steady policy life expectancy, investment in technology and a solid capital position.
Should You Retain Voya Financial (VOYA) in Your Portfolio?
by Zacks Equity Research
Voya Financial (VOYA) stands to gain from higher investment income, lower fee-based margin, administrative expenses and prudent capital deployment.
5 Insurance Stocks to Buy Amid Soaring Government Bond Yields
by Nalak Das
We have narrowed our search to five insurers with strong potential for the rest of 2023. These are: AIZ, RNR, KNSL, ACGL, BRO.
Here's Why You Should Hold Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from higher premiums, strategic acquisitions, favorable underwriting results and effective capital deployment.
Why You Should Add Radian Group (RDN) Stock to Your Portfolio
by Zacks Equity Research
Radian Group (RDN) is well-poised to grow, driven by improved persistence, high investment income and a strong capital position.
MetLife (MET) Ventures Into Single Family Rental Space in the US
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, ventures into single-family rental space with a new fund, securing capital commitments of $390 million.
Lincoln National (LNC) Unveils Tool to Ease Employee Onboarding
by Zacks Equity Research
Lincoln National (LNC) takes the help of GUIDEcx to bring a digital platform for hassle-free employee onboarding experience as a means to upgrade its group benefits offerings.
All You Need to Know About Assurant (AIZ) Rating Upgrade to Strong Buy
by Zacks Equity Research
Assurant (AIZ) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should You Retain Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Assurant (AIZ) stands to gain from organic growth across distribution channels, higher yields on fixed maturity securities, rise in invested assets and a solid capital position.
MGIC (MTG) Gains From Insurance Written as Expense Woes Stay
by Zacks Equity Research
Solid insurance in force, a decline in loss and claims payments and lower delinquency poise MGIC Investment (MTG) for growth. However, an increase in underwriting and other expenses weigh on margins.
Blue Owl Capital (OBDC) Q2 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Blue Owl Capital's (OBDC) Q2 results reflect record high net investment income on the back of increased portfolio average yield, partially offset by an increase in operating expenses.
Is Arch Capital Group (ACGL) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Arch Capital Group (ACGL) and Assurant (AIZ) have performed compared to their sector so far this year.
ProAssurance (PRA) Q2 Earnings Beat on Strong Investment Income
by Zacks Equity Research
ProAssurance's (PRA) Q2 results reflect higher net premiums earned in the Segregated Portfolio Cell Reinsurance unit, partly offset by rising costs.
Assurant (AIZ) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Assurant's (AIZ) second-quarter results reflect higher lender-placed net earned premiums, average insured values and premium rates and improved net investment income, offset by higher expenses.
Assurant (AIZ) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Assurant (AIZ) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Assurant (AIZ) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Assurant (AIZ) delivered earnings and revenue surprises of 49.62% and 4.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
CNO Financial (CNO) Lags Q2 Earnings Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of -21.74% and 11.76%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Assurant (AIZ) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Assurant's (AIZ) second-quarter performance is likely to benefit from organic growth from strong sales in Global Automotive, improved yields on fixed maturity securities, higher average insured values and premium rates.
Higher Premiums to Aid CNA Financial (CNA) in Q2 Earnings?
by Zacks Equity Research
Higher new business, rate increase, positive renewal premium change and retention across its segments are likely to have driven premiums for CNA Financial (CNA) in Q2.
Is a Beat in Store for Aflac (AFL) This Earnings Season?
by Zacks Equity Research
Aflac's (AFL) Q2 results are likely to reflect improved net investment income within its U.S. business and lower operating costs.